PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 15, 1999Statistics in Medicine360 citations

Combining mortality and longitudinal measures in clinical trials

View Full Paper
DFDianne M. FinkelsteinDSDavid Schoenfeld

Key Points

  • This research aims to develop a non-parametric test that integrates mortality and longitudinal measures in clinical trials for better treatment assessment.
  • Proposed a non-parametric test combining time to event and longitudinal measures.
  • Applied the test to AIDS prophylaxis and pediatric clinical trials.
  • A significant treatment difference on either measure led to rejection of the null hypothesis.
  • The proposed method showed effectiveness in evaluating therapeutic benefits in clinical settings.

Abstract

Clinical trials often assess therapeutic benefit on the basis of an event such as death or the diagnosis of disease. Usually, there are several additional longitudinal measures of clinical status which are collected to be used in the treatment comparison. This paper proposes a simple non-parametric test which combines a time to event measure and a longitudinal measure so that a substantial treatment difference on either of the measures will reject the null hypothesis. The test is applied on AIDS prophylaxis and paediatric trials.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Finkelstein et al. (1999) studied this question.

synapsesocial.com/papers/69d9b77f5e5bcb4e3b837bb0https://doi.org/10.1002/(sici)1097-0258(19990615)18:11<1341::aid-sim129>3.0.co;2-7
Ask AI
Helpful
Bookmark
Share
View Full Paper